共查询到20条相似文献,搜索用时 62 毫秒
1.
β1-型转化生长因子(TGF-β1)对细胞的抑制作用通过细胞周期中多种非独立的、具有协同作用的通道来完成。Cdk家族可能是TGF-β1抑制信号的最终靶蛋白。TGF-β1对Cdk的负调节作用,可能是通过激活或增加Cdk抑制物如p16^INK4A、p15^INK4B、p21^Wafl/Cipl或p27^Kipl的表达。另外,TGF-β1还可抑制G1期c-myc基因的表达。 相似文献
2.
ACOMPARISONINHEALINGOFSKULLDEFECTREPAIREDWITHFOURDIFFERENTKINDSOFGRAFTMATERIALSINRAB┐BITSDINGZhen-qi(丁真奇)1,TANFu-sheng(谭富生)2,... 相似文献
3.
EM Bill Farquhar M.S 《中国运动医学杂志》1998,17(2)
ANTI-INFLAMMATORYDRUGS,KIDNEYFUNCTION,ANDEXERCISEBillFarquhar,M.S.NollPhysiologicalResearchCenter,ThePennsylvaniaStateUnivers... 相似文献
4.
5.
烟雾病的磁共振成像诊断 总被引:2,自引:0,他引:2
目的:回顾分析8例烟雾病的磁共振成像表现,探讨磁共振成像对烟雾病的诊断价值。方法:8例烟雾病中男女各4例。年龄4~49岁,平均20.4岁。磁共振成像应用Siemens1.0TMR系统和头表面线圈。均有SE序列T1WI和T2WI,7例有三维时间飞跃法磁共振血管造影(3D-TOFMRA),1例有DSA。结果:SE序列MRI均见丘脑-基底节区(单侧2例,双侧6例)有扩张的烟雾血管,其中以T1WI显示更为清楚直观。7例3D-TOFMRA和1例DSA均见ICA上端、MCA和ACA近端闭塞以及丘脑-基底节区的烟雾血管。这些病理血管分布侧别与SE序列磁共振成像所见一致。结论:SE序列磁共振成像和3D-TOFMRA是诊断烟雾病的有效方法。T1WI显示丘脑-基底节区烟雾血管优于T2WI。3D-TOFMRA尚适用于烟雾病血管旁路术后随诊及其高危人群普查。 相似文献
6.
《中国运动医学杂志》1998,(4)
METHODSANDSTRATEGIESFORWEIGHTLOSSINATHLETESParticipants:PriscillaClarkson,Ph.DDept.ofExerciseScienceUniversityofMassachusetts... 相似文献
7.
THREE┐DIMENSIONALMOTIONMEASUREMENTOFTHEAT┐LANTOAXIALJOINTLUYi-sheng(卢一生),JIALian-shun(贾连顺),DINGZhu-quan(丁祖泉),DAILi-yang(戴力扬)O... 相似文献
8.
9.
Ronald J.Maughan Ph.D 《中国运动医学杂志》1998,17(1):71-152
PREPARINGATHLETESFORCOMPETITIONINTHEHEAT:DEVELOPINGANEFFECTIVEACCLIMATIZATIONSTRATEGYRonaldJ.Maughan,Ph.d.Member,GSSISportsMe... 相似文献
10.
11.
血小板第4因子造血保护作用的实验研究 总被引:3,自引:1,他引:2
目的 :研究血小板第 4因子 (PF4)对环磷酰胺 (CTX)处理小鼠体内造血系统的保护作用。方法 :实验鼠用PF4注射 2次 ,间隔 6h ,第二次注射后 2 0h给予CTX 2 0 0mg·kg- 1 。动态观察小鼠外周血白细胞数以及不同时期外周血T细胞亚群 ,骨髓粒-巨噬系集落形成单位 (CFU -GM)、细胞周期和小鼠脾脏、胸腺的变化。结果 :PF4能增加CTX处理小鼠骨髓CFU -GM的产率 ,加速体内CFU -GM的恢复 ;短时增加CTX处理小鼠骨髓G0 /G1 期细胞 ,减少骨髓细胞的坏死和凋亡 ;增加胸体比和脾体比。但是PF4对小鼠外周血白细胞数和T细胞亚群未见明显影响。结论 :PF4能保护小鼠骨髓及胸腺、脾脏等器官组织免受CTX损伤 ,增加骨髓CFU -GM的形成能力 相似文献
12.
13.
14.
Agata Błażewicz Elżbieta Bednarek Jerzy Sitkowski Magdalena Popławska Karolina Stypułkowska Wojciech Bocian Lech Kozerski 《Forensic Toxicology》2017,35(2):317-332
Over 560 new psychoactive substances have been detected via the European Union Early Warning System (EU-EWS) of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) between 2005 and 2015. Among them, 103 synthetic cathinones have been identified, which are the second largest group monitored by EMCDDA. National Medicines Institute in Poland analyzed over six thousands samples of designer drugs containing psychoactive substances from 2008 to 2015 by applying complementary techniques, i.e., liquid chromatography with high resolution mass spectrometry, gas chromatography with mass spectrometry, and nuclear magnetic resonance spectroscopy. Among over 150 identified psychoactive substances from different groups, the largest was an ensemble of substituted cathinones containing 48 items. Most of them were cathinones not covered by the Act on Counteracting Drug Addiction in Poland at the time of identification; however, they have been added successively to the list of banned compounds in the consecutive amendments of the Act. The present study describes the structure identification and spectral characterization of four novel substituted cathinones: hexedrone [2-methylamino-1-(phenyl)hexan-1-one], 4-BEC [1-(4-bromophenyl)-2-(ethylamino)propan-1-one], 4-Cl-PPP [1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)propan-1-one], and 4-Br-PVP [1-(4-bromophenyl)-2-(pyrrolidin-1-yl)pentan-1-one], seized prior to being sold on the drug market. They were identified for the first time by us and reported to EU-EWS EMCDDA. 相似文献
15.
16.
17.
18.
19.
20.